Rubius Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 11,877 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 11,877 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Stock Option (Right to Buy) 36,123 N/A N/A
Sale
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 36,123 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 36,123 N/A N/A
Option
NISSEN TORBEN STRAIGHT officer: President
Stock Option (Right to Buy) 207,146 N/A N/A
Option
NISSEN TORBEN STRAIGHT officer: President
Common Stock 207,146 N/A N/A
Option
NISSEN TORBEN STRAIGHT officer: President
Common Stock 207,146 $0.19 $38,322
Option
NISSEN TORBEN STRAIGHT officer: President
Stock Option (Right to Buy) 207,146 $0.19 $38,322
Option
LANGER ROBERT director
Stock Option (Right to Buy) 7,500 N/A N/A
Sale
LANGER ROBERT director
Common Stock 7,500 N/A N/A
Option
LANGER ROBERT director
Common Stock 7,500 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Stock Option (Right to Buy) 243 N/A N/A
Sale
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 243 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 243 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Stock Option (Right to Buy) 18,399 N/A N/A
Sale
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 18,399 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 18,399 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 10,858 N/A N/A
Sale
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 10,858 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Stock Option (Right to Buy) 10,858 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Stock Option (Right to Buy) 18,500 N/A N/A
Sale
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 18,500 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 18,500 N/A N/A
Sale
LANGER ROBERT director
Common Stock 7,500 N/A N/A
Option
LANGER ROBERT director
Stock Option (Right to Buy) 7,500 N/A N/A
Option
LANGER ROBERT director
Common Stock 7,500 N/A N/A
Sale
NISSEN TORBEN STRAIGHT officer: President
Common Stock 2,100 N/A N/A
Sale
NISSEN TORBEN STRAIGHT officer: President
Common Stock 12,096 N/A N/A
Sale
NISSEN TORBEN STRAIGHT officer: President
Common Stock 500 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 48,000 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Stock Option (Right to Buy) 48,000 N/A N/A
Sale
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 48,000 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Stock Option (Right to Buy) 34,843 N/A N/A
Option
CARPENTER CHRISTOPHER L. officer: Chief Medical Officer
Common Stock 34,843 N/A N/A
Option
LANGER ROBERT director
Stock Option (Right to Buy) 7,500 N/A N/A
Sale
LANGER ROBERT director
Common Stock 7,500 N/A N/A
Option
LANGER ROBERT director
Common Stock 7,500 N/A N/A
Purchase
CUSS FRANCIS M director
Common Stock 10,000 N/A N/A
Purchase
SOHN CATHERINE A. director
Common Stock 2,500 N/A N/A
Purchase
POMERANTZ ROGER director
Common Stock 100 N/A N/A
Purchase
SYMONDS JONATHAN director
Common Stock 25,000 N/A N/A

Showing 50 to 92 of 92 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.